3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
8
Breast Neoplasms
7
Uterine Cervical Neoplasms
5
Lung Neoplasms
5
Hematopoietic and Lymphatic System Neoplasm
4
Papillomavirus Infections
3
Liver Neoplasms
2
Hematologic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Overweight
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma
1
Liver Diseases
1
HER2+ Metastatic Breast Cancer (MBC)
1
Fibrosis
1
Diabetes Mellitus
1
Colorectal Cancer Screening
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Cancer Screening
1
Interventions
Magnetic Resonance Spectroscopy
3
Blood Specimen Collection
3
Specimen Handling
2
Simvastatin
2
Liver Transplantation
2
tremelimumab
1
sofosbuvir-velpatasvir drug combination
1
epigallocatechin gallate
1
durvalumab
1
atezolizumab
1
apixaban
1
User-Centered Design
1
Tocopherols
1
Surveys and Questionnaires
1
Standard of Care
1
Sodium Chloride
1
Sampling Studies
1
Radiotherapy
1
Radiation
1
Pravastatin
1
Phlebotomy
1
Pharmaceutical Preparations
1
Pentoxifylline
1
Patient Navigation
1
Neuropsychological Tests
1
Musculoskeletal Manipulations
1
Memantine
1
Losartan
1
Ketoprofen
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fibrosis
×
Patient Navigation
×
1 year
×
Clear all
NCT06458998
2026-02-23
GTI
University of Pittsburgh
Phase NA
Enrolling by invitation
30,300 enrolled